Pristine Surgical

Investment(s): 2019
Location: Manchester, NH

Pristine Surgical has developed a breakthrough in rigid endoscopy — the Pristine Surgical Single-Use Digital Imaging Platform. This first-of-its-kind, high-performance single-use rigid endoscope can improve over 23 million arthroscopic and laparoscopic procedures worldwide annually while reducing costs and lowering the risk of infection.

Theratome Bio

Investment(s): 2014
Location: Indianapolis, IN

Theratome Bio seeks to harness the protective and healing properties of the body’s own stem cells to transform the treatment of various diseases and conditions. Research and development efforts at Theratome Bio are focused on solutions for trans-arterial valve replacement (TAVR) and stroke.

* Theratome is held by Mend’s parent company, Ambassador Enterprises.